DrugPatentWatch Database Preview
Exela Pharma Science Company Profile
What is the competitive landscape for EXELA PHARMA SCIENCE, and what generic and branded alternatives to EXELA PHARMA SCIENCE drugs are available?
EXELA PHARMA SCIENCE has three approved drugs.
Summary for Exela Pharma Science
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 3 |
| NDAs: | 3 |
| Patent Litigation for Exela Pharma Science: | See patent lawsuits for Exela Pharma Science |
Drugs and US Patents for Exela Pharma Science
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma Science | NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 022276-003 | Apr 7, 2016 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Exela Pharma Science | CAFFEINE CITRATE | caffeine citrate | SOLUTION;INTRAVENOUS | 077233-001 | Sep 21, 2006 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Exela Pharma Science | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | SOLUTION;INTRAVENOUS | 207963-001 | Aug 22, 2016 | RX | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Exela Pharma Science | NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 022276-002 | Apr 7, 2016 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Exela Pharma Science | NICARDIPINE HYDROCHLORIDE | nicardipine hydrochloride | INJECTABLE;INJECTION | 022276-001 | Jul 24, 2008 | RX | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
